Analysis-US prices for new drugs fell in 2025 as fewer costly gene therapies were launched

Investing.com Gold reports: Analysis-US prices for new drugs fell in 2025 as fewer costly gene therapies were launched. Full body text was unavailable at ingest time, so this brief is based on headline context.